Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence

Curr Neuropharmacol. 2023;21(3):560-577. doi: 10.2174/1570159X20666221005090126.

Abstract

Despite being classified as a movement disorder, Parkinson's disease (PD) is characterized by a wide range of non-motor symptoms that significantly affect the patients' quality of life. However, clear evidence-based therapy recommendations for non-motor symptoms of PD are uncommon. Animal models of PD have previously been shown to be useful for advancing the knowledge and treatment of motor symptoms. However, these models may provide insight into and assess therapies for non-motor symptoms in PD. This paper highlights non-motor symptoms in preclinical models of PD and the current position regarding preclinical therapeutic approaches for these non-motor symptoms. This information may be relevant for designing future preclinical investigations of therapies for nonmotor symptoms in PD.

Keywords: Non-motor symptoms; Parkinson’s disease; patients' quality of life; preclinical models; rapid eye movement (REM); therapeutics.

MeSH terms

  • Humans
  • Parkinson Disease* / drug therapy
  • Quality of Life